Xenon Pharmaceuticals (XENE) Preferred Shares (2013 - 2021)

Xenon Pharmaceuticals (XENE) has 6 years of Preferred Shares data on file, last reported at $7.7 million in Q4 2021.

• Preferred Shares for Q4 2021 came in at $7.7 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2021 was $7.7 million (changed 0.0% YoY), and the FY2021 annual result was $7.7 million, changed 0.0% from the prior year.
• Preferred Shares held at $7.7 million in Q4 2021 per XENE's latest filing, from $7.7 million in the prior quarter.
• Over five years, Preferred Shares peaked at $21.8 million in Q1 2018 and troughed at $7.7 million in Q4 2018.
• A 4-year average of $9.8 million and a median of $7.7 million in 2018 frame the typical range for Preferred Shares.
• On a YoY basis, Preferred Shares climbed as much as 0.0% in 2019 and fell as far as 64.57% in 2019.
• A 4-year view of Preferred Shares shows it stood at $7.7 million in 2018, then changed by 0.0% to $7.7 million in 2019, then changed by 0.0% to $7.7 million in 2020, then changed by 0.0% to $7.7 million in 2021.
• Business Quant data shows XENE's Preferred Shares at $7.7 million in Q4 2021, $7.7 million in Q3 2021, and $7.7 million in Q2 2021.